Skip to main navigation Skip to search Skip to main content

CTF Meeting 2012: Translation of the Basic Understanding of the Biology and Genetics of NF1, NF2, and Schwannomatosis Toward the Development of Effective Therapies

  • Brigitte C. Widemann
  • , Maria T. Acosta
  • , Sylvia Ammoun
  • , Allan J. Belzberg
  • , Andre Bernards
  • , Jaishri Blakeley
  • , Antony Bretscher
  • , Karen Cichowski
  • , D. Wade Clapp
  • , Eva Dombi
  • , Gareth D. Evans
  • , Rosalie Ferner
  • , Cristina Fernandez-Valle
  • , Michael J. Fisher
  • , Marco Giovannini
  • , David H. Gutmann
  • , C. Oliver Hanemann
  • , Robert Hennigan
  • , Susan Huson
  • , David Ingram
  • Joe Kissil, Bruce R. Korf, Eric Legius, Roger J. Packer, Andrea I. Mcclatchey, Frank Mccormick, Kathryn North, Minja Pehrsson, Scott R. Plotkin, Vijaya Ramesh, Nancy Ratner, Susann Schirmer, Larry Sherman, Elizabeth Schorry, David Stevenson, Douglas R. Stewart, Nicole Ullrich, Annette C. Bakker*, Helen Morrison
*Corresponding author for this work
  • National Institutes of Health
  • Children's National Hospital
  • Johns Hopkins University
  • Harvard University
  • Cornell University
  • Indiana University Bloomington
  • University of Manchester
  • Guy's and St Thomas' NHS Foundation Trust
  • King's College London
  • University of Central Florida
  • University of Pennsylvania
  • University of Southern California
  • Washington University St. Louis
  • Cincinnati Children's Hospital Medical Center
  • Scripps Research Institute
  • University of Alabama at Birmingham
  • KU Leuven
  • University of California at San Francisco
  • The Children's Hospital at Westmead
  • Biomedicum Helsinki
  • Leibniz Institute on Aging - Fritz Lipmann Institute
  • Oregon Health and Science University
  • University of Utah
  • Children's Tumor Foundation (CTF)

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)563-578
Number of pages0
JournalAMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume164
Issue number3
DOIs
Publication statusPublished - 2014

Keywords

  • neurofibromatosis type 1
  • neurofibromatosis type 2
  • NF1
  • NF2
  • schwannomatosis
  • tumor suppressor
  • SMARCB1
  • merlin neurofibromin
  • preclinical models

Cite this